Connect MM: The multiple myeloma ( MM) disease registry-Incidence of second primary malignancies (SPM).

被引：0
|
作者：
Rifkin, Robert M.
Abonour, Rafat
Fonseca, Rafael
Gasparetto, Cristina
Mehta, Jayesh
Narang, Mohit
Pashos, Chris L.
Thomas, Sachdev P.
Shah, Jatin J.
Terebelo, Howard R.
Toomey, Kathleen
Minton, Neil
Srinivasan, Shankar
Street, Thomas
Sullivan, Kristen
Durie, Brian G.
机构：
[1] US Oncol Res, Denver, CO USA
[2] Indiana Univ Sch Med, Indianapolis, IN USA
[3] IU Melvin & Bren Simon Canc Ctr, Indianapolis, IN USA
[4] Mayo Clin, Scottsdale, AZ USA
[5] Duke Univ, Med Ctr, Durham, NC USA
[6] Northwestern Univ, Chicago, IL 60611 USA
[7] Alliance Hem & Onc, Westminster, MD USA
[8] United BioSource Corp, Lexington, MA USA
[9] Illinois Canc Care, Peoria, IL USA
[10] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[11] Newland Med Associates, Novi, MI USA
[12] Steeplechase Canc Ctr, Somerville, NJ USA
[13] Celgene Corp, Summit, NJ USA
[14] Clin Educ & Res Initiat Int Myeloma Fdn, North Hollywood, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8037
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Connect MM® the Multiple Myeloma (MM) Disease Registry: Incidence of Second Primary Malignancies (SPM)
    Rifkin, Robert M.
    Abonour, Rafat
    Shah, Jatin J.
    Mehta, Jayesh
    Narang, Mohit
    Terebelo, Howard R.
    Gasparetto, Cristina J.
    Thomas, Sachdev P.
    Toomey, Kathleen
    Hardin, James W.
    Lu, Jane Jie
    Kenvin, Laurie
    Srinivasan, Shankar
    Ricafort, Rosanna J.
    Nagarwala, Yasir
    Durie, Brian G. M.
    [J]. BLOOD, 2014, 124 (21)
  • [2] Connect MM® - the Multiple Myeloma Disease Registry: incidence of second primary malignancies in patients treated with lenalidomide
    Rifkin, Robert M.
    Abonour, Rafat
    Shah, Jatin J.
    Mehta, Jayesh
    Narang, Mohit
    Terebelo, Howard
    Gasparetto, Cristina
    Toomey, Kathleen
    Hardin, James W.
    Lu, Jane Jie
    Kenvin, Laurie
    Srinivasan, Shankar
    Knight, Robert
    Nagarwala, Yasir
    Durie, Brian G. M.
    [J]. LEUKEMIA & LYMPHOMA, 2016, 57 (09) : 2228 - 2231
  • [3] Investigation of Second Primary Malignancies (SPM) in Multiple Myeloma (MM) Patients Treated with Lenalidomide
    Minton, N.
    Castaneda, C.
    Weiss, L.
    Brandenburg, N.
    Gary, D.
    Freeman, J.
    Delap, R.
    Knight, R.
    Glasmacher, A.
    Rupalla, K.
    Zhang, J.
    Yu, Z.
    [J]. DRUG SAFETY, 2011, 34 (10) : 951 - 951
  • [4] Synchronous and metachronous second malignancies in multiple myeloma (MM).
    Wilkinson, Jennifer A.
    Fiala, Mark A.
    Vij, Ravi
    Finney, Joseph
    Stockerl-Goldstein, Keith
    Wildes, Tanya Marya
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] Connect MM® the Multiple Myeloma (MM) Disease Registry: Interim Analysis of Overall Survival and Outcomes in Patients with High-Risk Disease
    Shah, Jatin J.
    Abonour, Rafat
    Durie, Brian G. M.
    Mehta, Jayesh
    Narang, Mohit
    Terebelo, Howard
    Gasparetto, Cristina J.
    Thomas, Sachdev P.
    Toomey, Kathleen
    Hardin, James W.
    Srinivasan, Shankar
    Ricafort, Rosanna J.
    Nagarwala, Yasir
    Rifkin, Robert M.
    [J]. BLOOD, 2014, 124 (21)
  • [6] Connect MM Registry as a national reference for United States multiple myeloma patients
    Ailawadhi, Sikander
    Jagannath, Sundar
    Narang, Mohit
    Rifkin, Robert M.
    Terebelo, Howard R.
    Toomey, Kathleen
    Durie, Brian G. M.
    Hardin, James W.
    Gasparetto, Cristina J.
    Wagner, Lynne
    Omel, James L.
    Kumar, Vivek
    Yue, Lihua
    Kitali, Amani
    Agarwal, Amit
    Abonour, Rafat
    [J]. CANCER MEDICINE, 2020, 9 (01): : 35 - 42
  • [7] Incidence of second primary malignancies (SPM) after 6-years follow-up of continuous lenalidomide in first-line treatment of multiple myeloma (MM)
    Rossi, A. C.
    Mark, T. M.
    Jayabalan, D.
    Christos, P. J.
    Zafar, F.
    Pekle, K.
    Shore, T.
    Pearse, R. N.
    Leonard, J.
    Chen-Kiang, S.
    Coleman, M.
    Niesvizky, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [8] Real-World Utilization of Radiation Therapy (RT) in Multiple Myeloma (MM): An Analysis of the Connect® MM Registry
    Ballas, L. K.
    Ailawadhi, S.
    Narang, M.
    Gasparetto, C. J.
    Lee, H.
    Hardin, J. W.
    Durie, B. G. M.
    Toomey, K.
    Omel, J.
    Wagner, L. I.
    Abonour, R.
    Terebelo, H. R.
    Joshi, P.
    Yu, E.
    Liu, L.
    Rifkin, R. M.
    Jagannath, S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S133 - S134
  • [9] Heterogeneity of Second-Line Treatment for Patients With Multiple Myeloma in the Connect MM Registry (2010-2016)
    Jagannath, Sundar
    Abonour, Rafat
    Durie, Brian G. M.
    Gasparetto, Cristina
    Hardin, James W.
    Narang, Mohit
    Terebelo, Howard R.
    Toomey, Kathleen
    Wagner, Lynne
    Srinivasan, Shankar
    Kitali, Amani
    Yue, Lihua
    Flick, E. Dawn
    Agarwal, Amit
    Rifkin, Robert M.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (07): : 480 - +
  • [10] Incidence of secondary primary malignancies (SPM) in patients with multiple myeloma (CALM study)
    Firoozeh, S.
    Simona, I.
    Giulia, B.
    Linda, K.
    Didier, B.
    Peter, R.
    Russell, N. H.
    Per, L.
    Guido, K.
    Jiri, M.
    Jane, A.
    David, P.
    Paul, B.
    Wieslaw, W-J
    Stig, L.
    Schaap, N.
    Cecilia, I.
    Christof, S.
    Soledad, G. M.
    Alessandro, R.
    Patrice, C.
    Stefan, S.
    Curly, M.
    Laurent, G.
    Nicolaus, K.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S492 - S493
12345